Literature DB >> 29906645

More than cholesterol catabolism: regulatory vulnerabilities in Mycobacterium tuberculosis.

Amber C Bonds1, Nicole S Sampson2.   

Abstract

Mycobacterium tuberculosis (Mtb) is the epitome of persistent. Mtb is the pathogen that causes tuberculosis, the leading cause of death by infection worldwide. The success of this pathogen is due in part to its clever ability to adapt to its host environment and its effective manipulation of the host immune system. A major contributing factor to the survival and virulence of Mtb is its acquisition and metabolism of host derived lipids including cholesterol. Accumulating evidence suggests that the catabolism of cholesterol during infection is highly regulated by cholesterol catabolites. We review what is known about how regulation interconnects with cholesterol catabolism. This framework provides support for an indirect approach to drug development that targets Mtb cholesterol metabolism through dysregulation of nutrient utilization pathways.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29906645      PMCID: PMC6005656          DOI: 10.1016/j.cbpa.2018.05.012

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  52 in total

1.  Experimental evidence for the physiological role of bacterial luciferase in the protection of cells against oxidative stress.

Authors:  Hanna Szpilewska; Agata Czyz; Grzegorz Wegrzyn
Journal:  Curr Microbiol       Date:  2003-11       Impact factor: 2.188

2.  Identification of lysine succinylation as a new post-translational modification.

Authors:  Zhihong Zhang; Minjia Tan; Zhongyu Xie; Lunzhi Dai; Yue Chen; Yingming Zhao
Journal:  Nat Chem Biol       Date:  2010-12-12       Impact factor: 15.040

3.  Purification and characterization of the acetyl-CoA synthetase from Mycobacterium tuberculosis.

Authors:  Ru Li; Jing Gu; Peng Chen; Zhiping Zhang; Jiaoyu Deng; Xianen Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-09-06       Impact factor: 3.848

4.  Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase.

Authors:  Nisheeth Agarwal; Gyanu Lamichhane; Radhika Gupta; Scott Nolan; William R Bishai
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

5.  Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes.

Authors:  Kirsty J McLean; Ker R Marshall; Alison Richmond; Iain S Hunter; Kay Fowler; Tobias Kieser; Sudagar S Gurcha; Gurydal S Besra; Andrew W Munro
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

6.  Cyclic AMP-dependent protein lysine acylation in mycobacteria regulates fatty acid and propionate metabolism.

Authors:  Subhalaxmi Nambi; Kallol Gupta; Moitrayee Bhattacharyya; Parvathy Ramakrishnan; Vaishnavi Ravikumar; Nida Siddiqui; Ann Terene Thomas; Sandhya S Visweswariah
Journal:  J Biol Chem       Date:  2013-04-03       Impact factor: 5.157

7.  Negative transcriptional regulation of the mce3 operon in Mycobacterium tuberculosis.

Authors:  María P Santangelo; Jorge Goldstein; Alicia Alito; Andrea Gioffré; Karina Caimi; Osvaldo Zabal; Martín Zumárraga; Maria I Romano; Angel A Cataldi; Fabiana Bigi
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

8.  Characterization of an Aldolase Involved in Cholesterol Side Chain Degradation in Mycobacterium tuberculosis.

Authors:  Stephanie Gilbert; LaChae Hood; Stephen Y K Seah
Journal:  J Bacteriol       Date:  2017-12-20       Impact factor: 3.490

9.  The Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species.

Authors:  Selvakumar Subbian; Parmod K Mehta; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  BMC Microbiol       Date:  2007-01-19       Impact factor: 3.605

10.  Novel protein acetyltransferase, Rv2170, modulates carbon and energy metabolism in Mycobacterium tuberculosis.

Authors:  Wonsik Lee; Brian C VanderVen; Suzanne Walker; David G Russell
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

View more
  5 in total

Review 1.  Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Authors:  Adetomiwa A Adeniji; Kirsten E Knoll; Du Toit Loots
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-05       Impact factor: 4.813

2.  Mobile loop dynamics in adenosyltransferase control binding and reactivity of coenzyme B12.

Authors:  Romila Mascarenhas; Markus Ruetz; Liam McDevitt; Markos Koutmos; Ruma Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

3.  Post-translational Succinylation of Mycobacterium tuberculosis Enoyl-CoA Hydratase EchA19 Slows Catalytic Hydration of Cholesterol Catabolite 3-Oxo-chol-4,22-diene-24-oyl-CoA.

Authors:  Amber C Bonds; Tianao Yuan; Joshua M Werman; Jungwon Jang; Rui Lu; Natasha M Nesbitt; Miguel Garcia-Diaz; Nicole S Sampson
Journal:  ACS Infect Dis       Date:  2020-07-27       Impact factor: 5.084

Review 4.  Persistence of Intracellular Bacterial Pathogens-With a Focus on the Metabolic Perspective.

Authors:  Wolfgang Eisenreich; Thomas Rudel; Jürgen Heesemann; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2021-01-14       Impact factor: 5.293

5.  Crystal structure of Mycobacterium tuberculosis FadB2 implicated in mycobacterial β-oxidation.

Authors:  Jonathan A G Cox; Rebecca C Taylor; Alistair K Brown; Samuel Attoe; Gurdyal S Besra; Klaus Fütterer
Journal:  Acta Crystallogr D Struct Biol       Date:  2019-01-08       Impact factor: 7.652

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.